Product logins

Find logins to all Clarivate products below.


Facial Injectables | Asia Pacific | 2014 | Market Analysis

Valued at $588 million in 2013, the Asia Pacific market for facial injectables will be among the most rapidly growing global markets over the next ten years, expanding to reach a value of over $1.8 billion by 2022.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for facial injectables (including botulinum toxins and dermal fillers) in the Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Physician-Dispensed Cosmeceuticals – Market Insights – Europe
The European physician-dispensed cosmeceutical market will be driven by rising aesthetic consciousness, an aging population, and increasing demand for clinically validated skincare solutions. The…